Cat.#: ACPP-1322
| Despition | TRPM8 Blocking Peptide for Immunocompeition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1740 | Human RCAN1 Protein (AC1740) | 5 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1077 | CaMKII gamma Blocking Peptide (AC1077) | 250 µg | inquiry |
| ACPP-1649 | Human EFNA5 Protein (AC1649) | 2 µg | inquiry |
| ACPP-1684 | Human GNB3 Protein (AC1684) | 5 µg | inquiry |
| ACPP-1699 | Human Human Prealbumin (Active) Protein (AC1699) | 1 mg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1006 | Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.